coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Nantwich & Rural PCN, Cheshire East (LAD) · Health Inequalities Profile

    PCN U29951 · NHS Cheshire and Merseyside Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    36,866

    Registered population

    56.3% aged 18–64

    26.6%

    Aged 65+

    ICB 19.0% · England 17.9%

    3.6%

    Ethnic minority (non-White)

    1.2% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    6,874

    Hypertension register

    +7.67% in 3 yrs · England +5.60%

    291

    SMI register

    7.3% of Cheshire East (LAD)'s

    762

    COPD register

    Reviews +0.36% in 3 yrs

    Forecast to 2030

    8,288

    Hypertension patients, 2030

    +1,414 on today

    88.2%

    QRISK ≥20% on statins, 2030

    +9.72pp over 3 yrs

    6.9%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    65.4 pp
    Wide practice spread in telephone contact access.

    Easy phone contact ranges from 34.6% at The Kiltearn Medical Ctr. to 100.0% at The Surgery, which may reflect unverified local triage differences.

    76.6%
    Secondary-prevention and CKD statin prescribing trails England.

    Statin therapy in diabetes with CVD is 76.6% (England 84.4%) and 63.8% in CKD (England 70.3%), which could reflect recall gaps to audit locally.

    90.4%
    SMI blood pressure checks exceed national benchmarks.

    Annual blood pressure recording on the SMI register reaches 90.4% against 83.4% in England, rising +9.5 pp over 2023 to 2025 (England +4.4 pp).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65 and over make up 26.6% of the registered list

    Nantwich & Rural PCN cares for 36,866 registered patients across member practices. Patients aged 65+ make up 26.6% (9,806 patients), above Cheshire East (22.6%), the ICB (19.0%) and England (17.9%). Working-age adults aged 18-64 represent 56.3% and under-18s 17.1%, both below comparators. Census usual residents in associated areas are 96.4% White against Cheshire East (94.4%), the ICB (93.0%) and England (81.1%), leaving a 3.6% ethnic minority share; Census resident estimates do not match registered patients. Projected population growth to 2030 is 3.3% using an unverified methodology.

    Age profile

    0–1717.1%
    18–6456.3%
    65+26.6%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White96.4%
    Mixed1.6%
    Asian1.2%
    Other0.4%
    Black0.3%

    Older people · falls rows are Cheshire East (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Cheshire East LA)2,1292,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)81.6%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)59.9%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Cheshire East LA)9391,0219552024/25
    Falls deaths, all ages, per 100,000 (Cheshire East LA)14.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Deprivation is low with zero Core20 share recorded across all five member practices

    Nantwich & Rural PCN has an average IMD decile of 7.2, compared with 7.1 in Cheshire East, 5.2 in the ICB, and 5.5 in England. Its Core20 share is 0.0%, below Cheshire East (9.2%), the ICB (31.9%), and England (21.0%), representing an estimated zero Core20 patients. Across all five member practices Core20 prevalence is 0.0%, while average IMD deciles span from 6.6 at The Surgery to 7.9 at The Kiltearn Medical Ctr. Inequality work should focus on inclusion health and clinical risk rather than area deprivation.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Audlem Medical0.0% · 0 patients
    Nantwich0.0% · 0 patients
    Kiltearn Medical0.0% · 0 patients
    Tudor0.0% · 0 patients
    The0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    291

    SMI register

    0.80% recorded prevalence

    147

    Learning disability register

    0.40% recorded prevalence

    13

    Care homes, 643 beds

    In the PCN catchment

    8.8%

    Provide unpaid care

    Cheshire East (LAD), Census 2021

    Inclusion-health registers record 147 learning disability patients (0.4% against England 0.6%) and 291 severe mental illness patients (0.8% against England 1.0%). Catchment facilities include 13 care homes with 643 beds, though resident registrations and bed occupancy are not captured. Lower register prevalence may reflect local coding or case-finding differences, which local audit could clarify.

    Severe mental illness: physical health checks

    SMI blood pressure check coverage is 90.4% (Cheshire East 79.0%, ICB 81.3%, England 83.4%) and BMI recording is 87.1% (England 82.1%). Recorded checks exceed comparators, though single indicators do not establish comprehensive physical health review completion.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,874

    Hypertension register

    +7.67%

    Register growth, 3 yrs

    Cheshire East (LAD) +6.54% · England +5.60%

    +1.23pp

    BP control, under 80

    ≤140/90 · +2.73pp aged 80+

    +1,414

    More patients by 2030

    Forecast 8,288 (21.78%)

    Hypertension case-finding and control

    The PCN hypertension register holds 6,874 patients, representing 18.8% crude prevalence, compared with 17.3% in Cheshire East, 16.8% across the ICB, and 15.2% in England. The register grew +7.7% from 2023 to 2025, ahead of England (+5.6%). Clinical control is strong: 72.8% of patients are treated to target (England 70.3%), and 70.7% of those aged under 80 achieve blood pressure <= 140/90 mmHg (England 67.8%). However, three-year improvement in under-80 control (+1.8% vs England +3.2%) and recent blood pressure checks (+2.9% vs England +3.6%) trailed national progress. Maintaining proactive recall is important to ensure routine blood pressure monitoring keeps pace with national gains.

    Lipids and statins

    Although QRISK ≥ 20% lipid therapy grew +18.2% over 2023 to 2025 (England +6.2%), secondary prevention statin treatment trails England in diabetes with CVD (76.6% vs 84.4%) and CKD (63.8% vs 70.3%). Reviewing diabetic and renal registers could help identify patients eligible for secondary-prevention statin therapy.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202683,283£1.40£1.71£1.86£116,596
    Cardiovascular (all), 2025100,251£4.09£4.37£3.33£410,027

    In 2026, the PCN prescribed 83,283 lipid-regulating items at £1.40 per item, below Cheshire East (£1.72), the ICB (£1.71), and England (£1.86), spending £38,310 less than at England's unit cost. Lower unit cost than comparators does not establish prescribing efficiency, which local review of drug choice would test.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −0.31%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.41%

    Asthma prevalence, PCN 3-yr % change

    Annual review coverage exceeds national benchmarks for asthma (69.9% vs England 65.7%, Cheshire East 64.5%, ICB 62.3%) across 2,400 registered patients (prevalence 6.9%), and for COPD (80.8% vs England 76.4%, Cheshire East 74.5%, ICB 74.6%) across 762 patients (prevalence 2.1%). However, three-year review growth lags England in both asthma (-0.3% vs +4.4%) and COPD (+0.4% vs +2.8%), leaving an estimated 723 (about 720) asthma patients unreviewed. Prescribing of asthma management items for ages 5-19 is 1,366 per 1,000, below England's 1,488.

    Cancer register and children's immunisation

    Crude recorded cancer prevalence is 5.6%, compared with 4.9% in Cheshire East, 4.3% across the ICB, and 3.8% in England. Higher recorded prevalence does not establish unmet need or coding differences; local audit would verify diagnostic case-mix.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months98.5%

    England 91.0%

    6-in-1 complete primary course at 24 months98.7%

    England 92.2%

    MMR dose 1 at 24 months97.3%

    England 88.3%

    MMR dose 2 at age 596.2%

    England 82.8%

    4-in-1 pre-school booster at age 596.2%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    In 2022, 55.5% of cancers with a known stage (7,482 of 13,490) were diagnosed at stage 1 or 2 across NHS Cheshire and Merseyside ICB, comparable to England (55.3%), but 19.5 percentage points below the 75.0% national ambition by 2028. Staging was known for 72.8% of registered cancers (13,490 of 18,522, above England's 67.0%). Closing the gap to the 75.0% ambition requires about 2,640 additional early-stage diagnoses annually across the ICB. Staging varies by site, from 22.0% in oesophageal cancer to 87.1% in breast cancer, where smaller cohorts warrant caution. These system figures do not measure PCN performance.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Mid Cheshire Hospitals NHS Foundation Trust achieved 71.1% on the 62-day cancer standard (13.9 percentage points below the 85.0% standard), close to England (71.2%) but behind Countess of Chester Hospital NHS Foundation Trust (83.3%) and the ICB (76.2%), while exceeding University Hospitals of North Midlands NHS Trust (68.8%). Mid Cheshire reached 80.0% on the 28-day faster diagnosis standard (standard 75.0%; England 79.3%). Diagnostic 6-week waits were 5.2% for MRI and 1.1% for CT (England 21.4% and 9.9%). Provider waiting times reflect acute pressures rather than PCN performance.

    Pathways within standard (%)Mid Cheshireof North MidlandsCountess of ChesterCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)79.9580.6587.3777.2579.32
    31-day treatment (96%)86.2193.8593.4895.7192.50
    62-day referral to treatment (85%)71.1268.8483.2876.2371.16
    Diagnostic waits over 6 weeks (%)Mid Cheshireof North MidlandsCountess of ChesterEngland
    MRI5.1536.1311.2621.40
    CT1.092.864.189.92
    Echocardiography5.5145.3931.4428.48
    Colonoscopy30.3446.5326.4430.83
    Gastroscopy31.8915.4927.5229.02
    All 15 DM01 tests12.7222.9420.1623.14
    Community services activityCheshire East residentsCheshire and Merseyside ICB
    Care contacts72,825541,280
    Referrals18,28097,150
    Patients with a contact21,910146,240

    Community services (residents of Cheshire East), Jun 2026 (provisional). In June 2026, provisional community services data showed that adults aged 65 and over accounted for 60.8% of all community contacts among Cheshire East residents (44,295 of 72,825 contacts). This borough-level activity reflects substantial older-age service demand across community pathways, consistent with Nantwich & Rural PCN's older demographic profile, though community activity is not captured at PCN level.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    GP phone access spans 65.4 percentage points across the five member practices

    In 2025/26, overall QOF achievement ranged from 95.5% at The Surgery to 98.5% at Nantwich Health Centre (England 92.5%). Vaccination domain achievement showed a 36.0 pp spread across member practices. Domain achievement was 60.5% at The Surgery and 96.5% at Tudor Surgery (England 55.2%), while all-domain personalised care adjustments reached 12.5% at Tudor Surgery versus 4.5% at The Surgery.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    The Surgery1140.0100.0%80.1%99.3%
    Audlem Medical1210.079.3%75.6%88.5%
    Nantwich1050.059.2%82.9%85.1%
    Tudor Surgery860.069.6%56.7%80.0%
    Kiltearn Medical1110.034.6%68.8%66.2%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNCheshire East (LAD)AssetPCNCheshire East (LAD)
    Care homes (catchment)13 (643 beds)n/aSchools (catchment)46n/a
    Children's centres114Places of worship48272
    Libraries116Day centres (VCS)n/a1
    Children and young people (VCS)n/a1Carers support groups (VCS)n/a1
    Primary schools (LA maintained)941Primary academies1278
    Special schoolsn/a5

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Audit practice telephone and triage access

    In the 2026 GP Patient Survey, ease of phone contact spans 65.4 pp, from 34.6% at The Kiltearn Medical Ctr. to 100.0% at The Surgery (England 56.9%). For discussion, practices could review call demand, telephony routing and triage workflows at lowest-scoring sites and share effective access models. Moderate effort to run.

    Evidence base: patient-reported access and experience is the demand-side signal on primary-care capacity and access model; practices with sustained poor experience are the ones to prioritise for access-model support.

    Policy anchor: 10 Year Health Plan, shift from hospital to community (Neighbourhood Health Service).

    Option 2

    Standardise annual asthma review recall

    Asthma review coverage is 69.9% of 2,400 patients (England 65.7%), but 2023 to 2025 change was -0.3% vs England +4.4%, leaving 723 (about 720) unreviewed. For discussion, member practices could standardise annual asthma recall templates, align inhaler checks with reviews, and offer flexible clinic slots. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Validate learning disability register coding

    Learning disability prevalence is 0.4% (147 of 36,866 patients) vs Cheshire East 0.5% and England 0.6% (+22 to +70 benchmark gap range), growing +2.2% vs England +5.4%. For discussion, practices could search clinical systems for unlinked diagnostic codes and cross-check lists with local authority social-care records. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Frail older adult capacity review (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Inclusion health inequality pivot (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Hypertension recall audit (p5)Hypertension patients with a recent blood pressure readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Cancer pathway safety-netting audit (p7)Cancers diagnosed at stage 1 or 2 (All cancer sites)—ICB
    Telephone access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Audit practice telephone and triage access (p12)GPPS easy to contact the practice by phone · GPPS survey response rate10YHP, hospital to communityPractice
    Option 2 · Standardise annual asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · Validate learning disability register coding (p12)Learning disability register · Learning disability: QOF prevalence · Registered population75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15